Nexalin Technology Inc.'s Warrants Expire and are Delisted from Nasdaq, Common Stock Continues Trading Under Symbol NXL

Reuters
Sep 23
Nexalin Technology Inc.'s Warrants Expire and are Delisted from Nasdaq, Common Stock Continues Trading Under Symbol NXL

Nexalin Technology Inc. announced that its warrants, exercisable for one share of common stock at an exercise price of $4.15, expired on September 22, 2025, at 5:00 PM eastern time. These warrants, issued in connection with the company's initial public offering, have been delisted from the Nasdaq Stock Market following their expiration. Despite the expiration and delisting of the warrants, Nexalin Technology's common stock will continue to trade on the Nasdaq Capital Market under the symbol NXL.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-007572), on September 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10